Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New pain monitor tested on tiny babies during breathing treatment

NCT ID NCT06150586

Knowledge-focused Sponsor: University of Zurich Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new way to measure pain in preterm infants during a procedure called LISA, where surfactant is given to help them breathe. Researchers used skin conductance, which tracks nerve signals, and compared it to a standard pain scale. The goal was to see if this method could better identify which babies need pain relief.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could lead to better pain assessment tools for preterm infants, helping doctors decide when pain relief is needed during procedures.
What could go wrong
This is a small, completed study with only 21 infants, so results may not apply to all preterm babies. The method is still experimental and needs more testing.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

21 people

The number who actually took part.

Started

Dec 2023

Finished

Jun 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

All preterm infants with ≥27 0/7 weeks of gestation at birth who meet the inclusion criteria and who do not fulfill the exclusion criteria

Ages

Up to 48 hours

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Preterm infants ≥27 0/7 weeks of gestation at birth * Need for surfactant therapy via LISA according to the local standard operating procedure * ≥27 0/7 weeks of gestation, * within first 48 hours of life * FiO2 ≥0.30 to maintain SpO2 ≥90% for 15 min, * non-invasive respiratory support with PEEP 6-8 cmH2O * consent of attending NICU staff for videorecording Exclusion Criteria: * Primary intubation in the delivery room * Severe congenital malformation or other conditions requiring immediate endotracheal intubation * Insufficient language skills (German or English) of the parents to understand and consent the participation in the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Infant, premature, diseases are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

adult acute respiratory distress syndrome Infant, Premature, Diseases newborn respiratory distress syndrome Pain Pulmonary Atelectasis respiratory distress syndrome in premature infants

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Infant, premature, diseases Pain Respiratory distress syndrome Stress Surfactant deficiency syndrome neonatal

Contacts and locations

Locations

  • University Hospital Zurich

    Zurich, CH-8091, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.